Published in Lab Business Week, May 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Antigenics.
Report 1: Antigenics Inc. (NASDAQ: AGEN) today announced the appointment of Brian Corvese to its board of directors. Mr. Corvese is currently president and founder of Vencor Capital. He was formerly a partner at Soros Fund Management as well as a partner at Chancellor Capital Management.
"With more than 25 years of financial and investment experience, Brian brings a valuable portfolio of assets to Antigenics as a board member. We look forward to his guidance, having had an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week